Public Database for Biomedical Research Funding and Drug Prices Transparency
This law mandates the creation of a public, searchable database detailing all federal support (grants, contracts, tax benefits) for the development of drugs, therapies, and medical devices. The key impact for citizens is the requirement to disclose the final prices of these products, allowing the public to track how taxpayer money influences healthcare costs. This significantly increases transparency in public health investments.
Key points
Requires a public database detailing federal support for biomedical research and development.
Mandates disclosure of full funding terms, including tax benefits and use of federal resources.
Companies must report the final prices and manufacturing capacity of products developed with taxpayer support.
Expired
Citizen Poll